Drug Patent Watch
NOVEMBER 11, 2024
Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.
STAT
NOVEMBER 12, 2024
The last time Mark Palinski went to a Narcotics Anonymous meeting, he was asked to leave and never come back. He stills remembers the argument: All he had done was advocate for the use of the “gold standard” treatment opioid addiction, a common medication called buprenorphine. To Palinski, buprenorphine is a godsend.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharmacist
NOVEMBER 13, 2024
Pharmacy owners in England, Wales and Northern Ireland have voted in favour of taking collective action, according to a ballot carried out by the National Pharmacy Association (NPA). Some 99% of participating pharmacy owners said they were willing to limit their services unless funding is improved. The NPA said that subject to agreement from its […] The post Pharmacy owners vote overwhelmingly in favour of collective action appeared first on The Pharmacist.
PharmaVoice
NOVEMBER 11, 2024
Psychiatry is getting more targeted as drugmakers develop a new range of treatments for depression.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Express Pharma
NOVEMBER 13, 2024
The 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26-28, 2024, at the India Expo Centre, Greater Noida, Delhi-NCR. Renowned as a comprehensive, one-stop destination for innovative, cost-effective solutions, the expo will be showcasing the pharmaceutical industry’s modernisation, innovation, and sustainability.
STAT
NOVEMBER 12, 2024
Pfizer’s promising research on a treatment for a dangerous cancer-related condition is also helping prove out the value of wearables in clinical trials. In September, the pharma giant reported results showing that an experimental antibody could positively impact people with cachexia, a complication sometimes called “wasting syndrome” that can cause people with cancer to lose weight and make it harder for them to tolerate treatments.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmafile
NOVEMBER 13, 2024
Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the European Medicines agency (EMA) for the approval of a new indication for DARAZALEX FASPRO (daratumumab and hyluronidase-fihj). DARAZLEX FASPRO would be used as a monotherapy for the treatment of high-risk smoldering multiple myeloma in adult […] The post J&J seek approval for first drug to treat high-risk smoldering myeloma appeared first on Pharmafile.
Safe Biologics
NOVEMBER 14, 2024
SAVE THE DATE: ASBM and GaBI to Present Webinar on the Biosimilar Red Tape Elimination Act October 31st On October 31st, ASBM and the Generics and Biosimilar Initiative will present a webinar focusing Senate Bill 2305, the Biosimilar Red Tape Elimination Act. Health policy experts will review current U.S. biosimilar approval and substitution policies, discuss the rationale behind them, and examine the potential consequences of the proposed changes.
STAT
NOVEMBER 13, 2024
Sen. John Thune (R-S.D.), the newly elected Senate majority leader, is big on telehealth, rural hospitals, and increasing transparency for drug middlemen. As majority leader, Thune will be in charge of coordinating the entire Republican policy agenda, and it’s not clear how health care will fit into the mix. He represents a state that does not have much in the way of special interests in the health care industry beyond hospitals, doctors, and pharmacists.
The Pharmacist
NOVEMBER 15, 2024
Claire Burrows, partner at Brabners LLP and Thorrun Govind, solicitor at Brabners LLP, pharmacist and TV health expert, provide further insight into ongoing MHRA work on legislation covering medical devices. If you missed their last piece click here. The explosion of innovation in health technology in recent years has the potential to bring transformative approaches […] The post Post-market surveillance requirements for medical devices: Implications appeared first on The Pharmacist.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Express Pharma
NOVEMBER 10, 2024
Lupin, a global pharmaceutical company, has announced its tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. The approval enables Lupin to market a generic equivalent of Isentress HD Tablets, 600 mg, produced by Merck Sharp & Dohme LLC. Lupin is the exclusive first-to-file applicant for this product, potentially granting it a 180-day exclusivity period in the U.S. market.
The Guardian - Pharmaceutical Industry
NOVEMBER 9, 2024
As UK diagnoses have doubled, prescriptions of the treatment have halved. While experts feud over its use, many patients feel it is an effective way of managing their condition Occupational stress is a trigger for Rebecca Wilde, a 32-year-old tech worker in Buckinghamshire. Four years ago, work pressures combined with family issues affected her sleep, leading to a severe manic episode.
STAT
NOVEMBER 12, 2024
The company behind ChatGPT didn’t set out to tackle health care.
The Pharmacist
NOVEMBER 14, 2024
Community pharmacy leaders across the sector have called for uplifted funding to stop pharmacy closures and ease pressures, stressing that the current arrangements are putting patient safety at risk. This comes as the National Pharmacy Association (NPA) announced that 99% of participating pharmacy owners voted to limit their services unless funding is improved.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Express Pharma
NOVEMBER 11, 2024
ALK announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals. The agreement grants ALK exclusive global rights to the neffy adrenaline (epinephrine) nasal spray, with the exception of the USA, Australia, New Zealand, Japan and China. neffy is a needle-free emergency treatment for patients experiencing acute and potentially life-threatening allergic reactions.
Drug Patent Watch
NOVEMBER 12, 2024
Generic drug development is a crucial aspect of the pharmaceutical industry, providing cost-effective alternatives to brand-name medications. However, this process is not without its challenges. Here are the top 10 challenges faced by generic drug developers: Generic drug development involves navigating complex regulatory frameworks, including the U.S.
STAT
NOVEMBER 13, 2024
In the wake of the Covid-19 pandemic, the Food and Drug Administration continues to struggle with a lack of investigators needed to inspect domestic and foreign pharmaceutical manufacturing plants and has not yet developed a plan to keep needed staff, a U.S. government watchdog found. Between November 2021 and this past June, the vacancy rate among investigators increased to 16% from 9%.
The Pharmacist
NOVEMBER 15, 2024
A delegation of community pharmacists is set to meet with the UK Government's minister for Northern Ireland, Fleur Anderson, next month to discuss rising financial challenges facing the sector. The group will be led by Ulster Unionist Party peer Lord Rogan who said local pharmacies had been dispensing at a loss for 'far too long', […] The post Northern Ireland's pharmacists to meet with minister after vote to reduce services appeared first on The Pharmacist.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Express Pharma
NOVEMBER 14, 2024
Cadila Pharmaceuticals has launched Militol, an iron supplement designed to provide a precise combination of nutrients that maximise absorption and enhance tolerance, effectively addressing iron deficiency. Militol’s supplements contain ferric maltol, a low-dose form of ferric iron complexed with maltol. It also includes folic acid to promote red blood cell production, vitamin B12 for neurological health and red blood cell formation, vitamin C to enhance iron absorption and support immune health
Drug Channels
NOVEMBER 13, 2024
Uh oh. As I predicted, the stand-alone Medicare Part D prescription drug plans (PDP) market is vanishing. For 2025, DCI’s exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that the number of PDPs will drop to a historic low. What’s more, the share of plans with a preferred cost sharing pharmacy network will fall to its lowest rate in more than 10 years.
STAT
NOVEMBER 14, 2024
As a medical intern in the late 1980s, I’d occasionally see priests and rabbis on hospital wards, but we basically ignored one another. When we doctors walked into a patient’s room, they’d quickly leave, and when we exited, they’d enter. They seemed to operate in a wholly different realm. After all, we were scientific.
The Pharmacist
NOVEMBER 14, 2024
The government has urged pharmacies to work with ministers to achieve 'a service fit for the future', following a vote by pharmacy owners in favour of collective action. The Department of Health and Social Care said it was 'committed to working with the sector and would encourage all pharmacists to work with us'. This comes […] The post Government encourages pharmacists to 'work with us' appeared first on The Pharmacist.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Express Pharma
NOVEMBER 11, 2024
Purple Life Sciences, a company focused on harnessing natural ingredients for medical treatment, launched PSOCARE, a healing oil for psoriasis, at an event today. This product marks one of the initial offerings from the research-led organisation, developed to manage psoriasis symptoms, including red patches, dry and cracked skin, itching, burning, flaking, scaling, and plaque formation.
pharmaphorum
NOVEMBER 12, 2024
Virtual wards (also known as hospital at home) allow patients to get the care they need at home safely and conveniently, rather than being in hospital. The NHS is increasingly introducing virtual wards to support people at the place they call home, including care homes. In today’s podcast, web editor Nicole Raleigh speaks with Dr Samuel Ewing, global head of pharma partnerships at Doccla, about the next generation of digital tools such as wearable medical devices, as well as remote patient monit
STAT
NOVEMBER 12, 2024
Biotech startup Orna Therapeutics has cut more jobs in its second round of layoffs in the last year, STAT has learned. Orna was part of a buzzy cohort of companies established in the wake of the Covid pandemic, planning to create a new, more durable type of RNA-based medicines. It launched in 2021 and quickly garnered attention from Gilead subsidiary Kite Pharma, Bristol Myers Squibb, Novartis, and Merck.
The Pharmacist
NOVEMBER 13, 2024
We caught up with the Pharmacist/Pharmacy Team of the Year Award shortlist ahead of this year’s General Practice Awards ceremony to be held on 6 December at the Novotel London West. The Orpington PCN Pharmacy Team has grown from a group of five to a thriving team of 13 over the past 18 months, comprising […] The post GP Awards shortlist: Orpington PCN Pharmacy Team appeared first on The Pharmacist.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
PharmaVoice
NOVEMBER 13, 2024
As the industry’s marketing dollars shift, companies are targeting potential patients in unique ways.
Express Pharma
NOVEMBER 12, 2024
STEERLife, and Callidus Research Laboratories have forged a strategic partnership to accelerate drug development for global markets. The collaboration combines STEERLife’s advanced hot melt extrusion (HME) and continuous processing technologies with Callidus’ Pharmaceutical drug development expertise, to address the global demand for innovative drug formulations and development.
STAT
NOVEMBER 13, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning, lots of news this morning that we’ll get straight into.
The Pharmacist
NOVEMBER 13, 2024
A pharmacogenetics pilot supported by pharmacists working within general practice has resulted in medicines changes for 25% of participating patients so far, Royal Pharmaceutical Society (RPS) conference attendees heard last week. Jessica Keen, pharmacy lead at the NHS North West Genomic Medicines Service Alliance, shared an update on the NHS England-funded Pharmacogenetics Roll Out – Gauging Response to Service (PROGRESS) […] The post Pharmacogenetics pilot in general practice suggests 25
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
101 
Let's personalize your content